Polo-like kinase 1 suppresses lung adenocarcinoma immunity through necroptosis.

Zhang, Pengcheng; Zhang, Xinglong; Zhu, Yongfu; Cui, Yiyi; Xu, Jing; Zhang, Weiping

Zhang, Pengcheng; Zhang, Xinglong; Zhu, Yongfu; Cui, Yiyi; Xu, Jing; Zhang, Weiping.

Afiliação

Zhang P; Department of Oncology, The Third Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, China.
Zhang X; Department of Oncology, Anhui Zhongke Gengjiu Hospital, Hefei, China.
Zhu Y; Department of Oncology, The First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei, China.
Cui Y; Department of Oncology, The Third Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, China.
Xu J; Department of Biochemistry and Molecular Biology, School of Integrated Chinese and Western Medicine, Anhui University of Chinese Medicine, Hefei, China.
Zhang W; Department of Oncology, The Third Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, China.

Oncol Res ; 31(6): 937-953, 2023.

Article em En | MEDLINE | ID: mdl-37744268

Palavras-chave

Immune infiltration; Lung adenocarcinoma; Necroptosis; PLK1; Prognosis biomarker

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Oncol Res Assunto da revista: NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google